ALKBH5 is elevated in epithelial ovarian cancer, silencing of ALKBH5 enhances the autophagy signaling and inhibits the proliferation and invasion abilities of ovarian cancer cells by reducing EGFR/PI3K/AKT signaling activity through physically interacting with HuR204. Here, AKT1 is linked to ovarian carcinoma.